Dr. Norbert Tavares is a 2017-19 AAAS Science & Technology Policy Fellow in the Center for Strategic Scientific Initiatives (CSSI) at NIH/NCI. In his role, he supports the goals of CSSI to identify and promote emerging and innovative solutions to cancer research problems. He is involved in ongoing trans-NCI/NIH programs, including the Provocative Questions Initiative, a joint NIEHS-NCI program evaluation (HITS) pilot, and projects related to the Beau Biden Cancer MoonshotSM Initiative, such as the Human Tumor Atlas Network. Other areas of interest include early-stage investigator training and support and building convergence/transdisciplinary collaborations, in particular, the intersection and application of microbial oncology, ecology, and microbiome to better understand and treat cancers.
Dr. Tavares is a microbiologist with a background in bacterial genetics, biochemistry, and enzymology. His previous research area involved the investigation of the bacterial and archaeal biosynthetic pathways of coenzyme B12, and the regulation of metabolism by Sirtuin-dependent posttranslational modification via acylation/deacylation in Salmonella enterica. He started his Ph.D. at the University of Wisconsin, then moved with his lab to the University of Georgia where he received his doctorate in microbiology. Prior to his graduate work, Dr. Tavares had a brief stint as a research associate at CuraGen Corporation where he was involved in the process validation of large-scale bacterial protein drug production. He also has four years of procurement experience for ESPN/Disney Corporation. Dr. Tavares has strong interests in solving high impact problems and advancing science by supporting basic research, rigor, reproducibility, transparency, and the advancement of women and underrepresented individuals in science and other areas.